Payment overview · 2025
General Payments
$156.47
5 reported records · 3 companies
Healthcare provider profile · identity verified
Lloyd Arden Bonner, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · RICHMOND, VA · NPI 1821086646
Verified facts
What the public records show
CMS Open Payments records show Lloyd Arden Bonner, M.D. received $156.47 in general payments during 2025 across 5 reported records.
Novo Nordisk Inc accounted for 68.7% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 5 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 172 claims for Ozempic by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 26 claims for Rybelsus by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $107.45 | 68.7% | 2 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $31.80 | 20.3% | 2 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $17.22 | 11.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $156.47 | 5 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Wegovy Normalized: wegovy |
Drug | Novo Nordisk Inc | $58.16 | 1 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $49.29 | 1 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $31.80 | 2 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $17.22 | 1 | 2025 |
Source payment records
|
|||||
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $14.09 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 172 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
172 | 25 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Rybelsus open payments reported associated product |
CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076 |
Rybelsus · 2024 Exact normalized brand match · 1 Part D row |
26 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 1387 | 358 |
| Atorvastatin Calcium | Atorvastatin Calcium | 1042 | 299 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 574 | 153 |
| Meloxicam | Meloxicam | 485 | 111 |
| Metformin Hcl Er | Metformin Hcl | 436 | 126 |
| Pantoprazole Sodium | Pantoprazole Sodium | 388 | 109 |
| Potassium Chloride | Potassium Chloride | 345 | 85 |
| Metoprolol Succinate | Metoprolol Succinate | 322 | 86 |
| Losartan Potassium | Losartan Potassium | 319 | 87 |
| Omeprazole | Omeprazole | 293 | 75 |
| Levothyroxine Sodium | Levothyroxine Sodium | 292 | 65 |
| Ezetimibe | Ezetimibe | 286 | 71 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 275 | 92 |
| Tamsulosin Hcl | Tamsulosin Hcl | 254 | 56 |
| Carvedilol | Carvedilol | 234 | 57 |
| Hydrochlorothiazide | Hydrochlorothiazide | 234 | 59 |
| Lisinopril | Lisinopril | 228 | 65 |
| Prednisone | Prednisone | 225 | 78 |
| Simvastatin | Simvastatin | 203 | 52 |
| Fluticasone Propionate | Fluticasone Propionate | 196 | 70 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 196 | 46 |
| Gabapentin | Gabapentin | 184 | 51 |
| Ozempic | Semaglutide | 172 | 25 |
| Eliquis | Apixaban | 159 | 25 |
| Montelukast Sodium | Montelukast Sodium | 148 | 36 |
| Furosemide | Furosemide | 147 | 39 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 145 | 37 |
| Finasteride | Finasteride | 144 | 36 |
| Pravastatin Sodium | Pravastatin Sodium | 142 | 41 |
| Allopurinol | Allopurinol | 135 | 30 |
| Metoprolol Tartrate | Metoprolol Tartrate | 131 | 34 |
| Clopidogrel | Clopidogrel Bisulfate | 115 | 29 |
| Trazodone Hcl | Trazodone Hcl | 114 | 26 |
| Fluoxetine Hcl | Fluoxetine Hcl | 106 | 25 |
| Tramadol Hcl | Tramadol Hcl | 106 | 25 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 106 | 31 |
| Spironolactone | Spironolactone | 104 | 26 |
| Famotidine | Famotidine | 95 | 27 |
| Lorazepam | Lorazepam | 95 | 22 |
| Glimepiride | Glimepiride | 90 | 28 |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 89 | 22 |
| Metformin Hcl | Metformin Hcl | 87 | 35 |
| Sertraline Hcl | Sertraline Hcl | 87 | 21 |
| Telmisartan | Telmisartan | 86 | 26 |
| Lovastatin | Lovastatin | 85 | 19 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 83 | 24 |
| Celecoxib | Celecoxib | 83 | 19 |
| Symbicort | Budesonide/Formoterol Fumarate | 80 | 23 |
| Donepezil Hcl | Donepezil Hcl | 78 | 23 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 78 | 22 |
| Clonidine Hcl | Clonidine Hcl | 77 | 19 |
| Meclizine Hcl | Meclizine Hcl | 76 | 25 |
| Diclofenac Sodium Er | Diclofenac Sodium | 71 | 14 |
| Nifedipine Er | Nifedipine | 68 | 22 |
| Bumetanide | Bumetanide | 67 | 19 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 67 | 15 |
| Chlorthalidone | Chlorthalidone | 66 | 16 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 66 | 17 |
| Ibuprofen | Ibuprofen | 66 | 22 |
| Ketoconazole | Ketoconazole | 64 | 25 |
| Alprazolam | Alprazolam | 63 | suppressed |
| Indapamide | Indapamide | 62 | 16 |
| Hydralazine Hcl | Hydralazine Hcl | 61 | 19 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 61 | 12 |
| Atenolol | Atenolol | 60 | 15 |
| Pioglitazone Hcl | Pioglitazone Hcl | 60 | 20 |
| Cefuroxime | Cefuroxime Axetil | 59 | 55 |
| Klor-Con M20 | Potassium Chloride | 58 | 22 |
| Levetiracetam | Levetiracetam | 56 | suppressed |
| Pregabalin | Pregabalin | 56 | 11 |
| Valsartan | Valsartan | 56 | 12 |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 55 | 17 |
| Warfarin Sodium | Warfarin Sodium | 55 | 13 |
| Dicyclomine Hcl | Dicyclomine Hcl | 50 | 11 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 50 | 16 |
| Naproxen | Naproxen | 49 | 17 |
| Diclofenac Sodium | Diclofenac Sodium | 48 | 18 |
| Trulicity | Dulaglutide | 48 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 47 | 11 |
| Jardiance | Empagliflozin | 46 | 14 |
| Mounjaro | Tirzepatide | 46 | 11 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 46 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 46 | 15 |
| Duloxetine Hcl | Duloxetine Hcl | 45 | 12 |
| Myrbetriq | Mirabegron | 45 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 44 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 43 | 11 |
| Methocarbamol | Methocarbamol | 43 | 12 |
| Mirtazapine | Mirtazapine | 43 | 16 |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 43 | suppressed |
| Fluocinonide | Fluocinonide | 41 | 20 |
| Azithromycin | Azithromycin | 39 | 34 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 39 | 17 |
| Baclofen | Baclofen | 38 | 13 |
| Tresiba Flextouch U-200 | Insulin Degludec | 38 | 12 |
| Escitalopram Oxalate | Escitalopram Oxalate | 35 | suppressed |
| Topiramate | Topiramate | 35 | suppressed |
| Clonazepam | Clonazepam | 34 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 34 | 12 |
| Glipizide | Glipizide | 32 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 31 | 27 |
| Felodipine Er | Felodipine | 31 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 30 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 30 | 14 |
| Bupropion Xl | Bupropion Hcl | 30 | suppressed |
| Januvia | Sitagliptin Phosphate | 30 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 30 | suppressed |
| Tradjenta | Linagliptin | 30 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 29 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 29 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 27 | suppressed |
| Diazepam | Diazepam | 27 | suppressed |
| Irbesartan | Irbesartan | 27 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 26 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 26 | suppressed |
| Linzess | Linaclotide | 26 | suppressed |
| Memantine Hcl | Memantine Hcl | 26 | suppressed |
| Rybelsus | Semaglutide | 26 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 26 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 25 | 11 |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 25 | suppressed |
| Klor-Con M10 | Potassium Chloride | 25 | suppressed |
| Aripiprazole | Aripiprazole | 24 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 24 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 23 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 23 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 23 | 12 |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 23 | suppressed |
| Latanoprost | Latanoprost | 23 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 23 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 22 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 22 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 22 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 21 | suppressed |
| Lacosamide | Lacosamide | 21 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 21 | suppressed |
| Risperidone | Risperidone | 21 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 20 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 20 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 19 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 19 | suppressed |
| Victoza 3-Pak | Liraglutide | 19 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 18 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 18 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 17 | suppressed |
| Fluconazole | Fluconazole | 17 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 17 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 17 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 17 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 17 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 17 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 17 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 16 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 16 | suppressed |
| Humulin N Kwikpen | Insulin Nph Human Isophane | 16 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 16 | suppressed |
| Acyclovir | Acyclovir | 15 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Cephalexin | Cephalexin | 15 | 15 |
| Colchicine | Colchicine | 15 | suppressed |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 15 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 15 | suppressed |
| Lactulose | Lactulose | 15 | suppressed |
| Lamotrigine | Lamotrigine | 15 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 15 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 15 | suppressed |
| Tiadylt Er | Diltiazem Hcl | 15 | suppressed |
| Torsemide | Torsemide | 15 | suppressed |
| Amoxicillin | Amoxicillin | 14 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 14 | suppressed |
| Calcium Acetate | Calcium Acetate | 14 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 14 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 14 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 14 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 14 | suppressed |
| Sucralfate | Sucralfate | 14 | suppressed |
| Clonidine | Clonidine | 13 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 13 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 13 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 13 | 13 |
| Prezcobix | Darunavir/Cobicistat | 13 | suppressed |
| Symtuza | Darunavir/Cob/Emtri/Tenof Alaf | 13 | suppressed |
| Synthroid | Levothyroxine Sodium | 13 | suppressed |
| Tivicay | Dolutegravir Sodium | 13 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 12 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 12 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 12 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 12 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Dulera | Mometasone/Formoterol | 12 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 12 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 12 | suppressed |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 12 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 12 | suppressed |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 12 | suppressed |
| Victoza 2-Pak | Liraglutide | 12 | suppressed |
| Xarelto | Rivaroxaban | 12 | suppressed |
| Droplet Insulin Syringe | Syringe And Needle,insulin,1ml | 11 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 11 | suppressed |
| Ondansetron Odt | Ondansetron | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $156.47 · 5 records | Novo Nordisk Inc | Cologuard Collection Kit, OTEZLA, Ozempic, REPATHA, Wegovy | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error